SG Americas Securities LLC Has $39.84 Million Stock Position in STERIS plc $STE

SG Americas Securities LLC grew its position in STERIS plc (NYSE:STE) by 10,510.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 157,135 shares of the medical equipment provider’s stock after acquiring an additional 155,654 shares during the quarter. SG Americas Securities LLC owned 0.16% of STERIS worth $39,837,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of STE. Magnolia Capital Advisors LLC raised its stake in shares of STERIS by 1.2% in the third quarter. Magnolia Capital Advisors LLC now owns 3,588 shares of the medical equipment provider’s stock valued at $888,000 after purchasing an additional 41 shares in the last quarter. Colonial Trust Co SC boosted its stake in STERIS by 0.3% during the third quarter. Colonial Trust Co SC now owns 12,329 shares of the medical equipment provider’s stock worth $3,051,000 after buying an additional 42 shares in the last quarter. Geneos Wealth Management Inc. increased its holdings in STERIS by 34.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 45 shares during the period. Fifth Third Bancorp increased its holdings in STERIS by 1.6% in the 3rd quarter. Fifth Third Bancorp now owns 2,953 shares of the medical equipment provider’s stock valued at $731,000 after buying an additional 46 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. raised its stake in shares of STERIS by 1.4% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,494 shares of the medical equipment provider’s stock valued at $865,000 after buying an additional 48 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Transactions at STERIS

In other STERIS news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the transaction, the director owned 705 shares in the company, valued at approximately $167,233.05. The trade was a 81.46% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.07% of the company’s stock.

Analyst Ratings Changes

STE has been the subject of a number of analyst reports. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 7th. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $275.20.

STERIS Price Performance

NYSE:STE opened at $223.69 on Thursday. The firm has a market cap of $21.94 billion, a PE ratio of 31.20 and a beta of 1.05. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. The company’s 50-day moving average price is $244.63 and its two-hundred day moving average price is $249.14.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same quarter last year, the business earned $2.32 earnings per share. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, equities analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were issued a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend was Tuesday, February 17th. STERIS’s dividend payout ratio (DPR) is currently 35.15%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.